X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14624) 14624
Book Chapter (50) 50
Magazine Article (46) 46
Newsletter (39) 39
Book / eBook (17) 17
Conference Proceeding (11) 11
Dissertation (3) 3
Newspaper Article (2) 2
Web Resource (2) 2
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8195) 8195
cephalosporins - pharmacology (6841) 6841
pharmacology & pharmacy (4797) 4797
microbial sensitivity tests (4756) 4756
anti-bacterial agents - pharmacology (4031) 4031
microbiology (3890) 3890
male (3667) 3667
female (3286) 3286
cephalosporins (3014) 3014
cephalosporins - therapeutic use (2922) 2922
animals (2559) 2559
infectious diseases (2401) 2401
adult (2118) 2118
middle aged (1758) 1758
bacteria - drug effects (1663) 1663
antibiotics (1633) 1633
cephalosporins - administration & dosage (1503) 1503
drug resistance, microbial (1449) 1449
aged (1447) 1447
anti-bacterial agents - therapeutic use (1395) 1395
cephalosporins - metabolism (1381) 1381
cephalosporins - pharmacokinetics (1251) 1251
escherichia coli - drug effects (1245) 1245
research article (1143) 1143
beta-lactamases - metabolism (1128) 1128
bacterial infections - drug therapy (1116) 1116
child (1073) 1073
beta-lactamases - genetics (974) 974
adolescent (973) 973
penicillins - pharmacology (972) 972
cephalosporin (947) 947
kinetics (944) 944
infections (898) 898
child, preschool (894) 894
resistance (882) 882
bacteria (873) 873
pseudomonas aeruginosa - drug effects (873) 873
enterobacteriaceae - drug effects (866) 866
escherichia-coli (842) 842
polycyclic compounds (835) 835
infant (827) 827
moxalactam (814) 814
penicillin resistance (810) 810
cephalosporins - adverse effects (791) 791
biochemical phenomena, metabolism, and nutrition (784) 784
mice (766) 766
staphylococcus aureus - drug effects (744) 744
drug resistance, bacterial (703) 703
ceftazidime (684) 684
antimicrobial resistance (677) 677
cefotaxime - pharmacology (659) 659
anti-bacterial agents - administration & dosage (652) 652
cephalosporins - blood (648) 648
gram-negative bacteria - drug effects (639) 639
time factors (635) 635
pharmacokinetics (627) 627
rats (608) 608
susceptibility (608) 608
drug resistance (606) 606
streptococcus pneumoniae - drug effects (599) 599
cephaloridine (587) 587
administration, oral (586) 586
enterobacteriaceae (579) 579
ceftazidime - pharmacology (575) 575
klebsiella pneumoniae - drug effects (558) 558
structure-activity relationship (554) 554
bacterial infections and mycoses (542) 542
cefepime (534) 534
penicillin (527) 527
ceftriaxone (526) 526
escherichia coli - genetics (502) 502
prevalence (500) 500
cephalosporin resistance (490) 490
epidemiology (490) 490
beta-lactamases - biosynthesis (483) 483
anti-bacterial agents - pharmacokinetics (482) 482
klebsiella-pneumoniae (476) 476
cephalosporins - chemistry (475) 475
cefotaxime (469) 469
bacterial infections - microbiology (468) 468
injections, intravenous (467) 467
treatment outcome (466) 466
beta-lactam antibiotics (457) 457
half-life (452) 452
aged, 80 and over (451) 451
escherichia coli - enzymology (450) 450
cephalosporins - chemical synthesis (448) 448
immunology (443) 443
antimicrobial agents (438) 438
urinary tract infections - drug therapy (434) 434
drug evaluation (433) 433
chemistry (418) 418
pharmacology (414) 414
pseudomonas-aeruginosa (413) 413
hospitals (408) 408
oncology (408) 408
staphylococcus - drug effects (394) 394
drug resistance in microorganisms (393) 393
ceftriaxone - pharmacology (388) 388
beta-lactam resistance (387) 387
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (15) 15
Chemistry (A D Allen) - Stacks (2) 2
Online Resources - Online (2) 2
UTL at Downsview - May be requested (2) 2
UofT at Mississauga - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Robarts - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13371) 13371
Japanese (1378) 1378
French (223) 223
German (166) 166
Spanish (115) 115
Russian (109) 109
Italian (82) 82
Chinese (72) 72
Polish (34) 34
Czech (18) 18
Romanian (16) 16
Turkish (13) 13
Slovak (12) 12
Dutch (9) 9
Hungarian (9) 9
Portuguese (8) 8
Bulgarian (4) 4
Croatian (4) 4
Finnish (4) 4
Norwegian (3) 3
Swedish (3) 3
Hebrew (2) 2
Lithuanian (2) 2
Danish (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2013, Volume 13, Issue 4, pp. 328 - 341
Summary Background Many meta-analyses have shown reductions in infection rates and mortality associated with the use of selective digestive decontamination... 
Infectious Disease | MULTIPLE-TRAUMA PATIENTS | CONTROLLED CLINICAL-TRIAL | RANDOMIZED CONTROLLED-TRIALS | INFECTIOUS DISEASES | VENTILATOR-ASSOCIATED PNEUMONIA | DOUBLE-BLIND | OROPHARYNGEAL DECONTAMINATION | PLACEBO-CONTROLLED TRIAL | NOSOCOMIAL INFECTION | DIGESTIVE-TRACT DECONTAMINATION | CRITICALLY-ILL PATIENTS | United States - epidemiology | Prevalence | Gram-Positive Bacteria - drug effects | Humans | Tobramycin - pharmacology | Drug Resistance, Bacterial | Intensive Care Units - statistics & numerical data | Disease Transmission, Infectious - prevention & control | Cross Infection - transmission | Polymyxins - pharmacology | Digestive System - drug effects | Decontamination | Gentamicins - pharmacology | Vancomycin - pharmacology | Neomycin - pharmacology | Nystatin - pharmacology | Odds Ratio | Cephalosporins - pharmacology | Cross Infection - epidemiology | Oropharynx - microbiology | Anti-Infective Agents, Local - pharmacology | Cross Infection - prevention & control | Methicillin-Resistant Staphylococcus aureus - drug effects | South Africa - epidemiology | Amphotericin B - pharmacology | Europe - epidemiology | Clinical Trials as Topic | Pseudomonas aeruginosa - drug effects | Cross Infection - drug therapy | Randomized Controlled Trials as Topic | Gram-Negative Bacteria - drug effects | Anti-Infective Agents, Local - administration & dosage | Cross Infection - microbiology | Fluoroquinolones - pharmacology | Enterobacteriaceae - drug effects | Primary Prevention - methods | Anti-Bacterial Agents - pharmacology | Aminoglycosides - pharmacology | Anti-Bacterial Agents - administration & dosage | Digestive System - microbiology | Oropharynx - drug effects | Drug resistance in microorganisms | Analysis
Journal Article
Journal Article
中华医学杂志:英文版, ISSN 0366-6999, 2017, Volume 130, Issue 6, pp. 659 - 664
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2016, Volume 60, Issue 12, pp. 7415 - 7423
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 04/2016, Volume 60, Issue 4, pp. 1974 - 1983
In this study, we tested five compounds belonging to a novel series of piperazine arylideneimidazolones for the ability to inhibit the AcrAB-TolC efflux pump.... 
MICROBIOLOGY | PHARMACOLOGY & PHARMACY | 5-ARYLIDENE AROMATIC DERIVATIVES | MULTIDRUG-RESISTANCE | IDENTIFICATION | PSEUDOMONAS-AERUGINOSA | Fluorescent Dyes - chemical synthesis | Protein Kinases - metabolism | Protein Kinases - genetics | Escherichia coli - drug effects | Cephalosporins - chemistry | Levofloxacin - pharmacology | Repressor Proteins - antagonists & inhibitors | Microbial Sensitivity Tests | Membrane Transport Proteins - genetics | Escherichia coli - metabolism | Linezolid - pharmacology | Biological Assay | Fluorescent Dyes - pharmacology | Membrane Transport Proteins - metabolism | Biological Transport - drug effects | Cell Membrane - metabolism | Membrane Proteins - metabolism | Escherichia coli - growth & development | Escherichia coli Proteins - antagonists & inhibitors | Imidazoles - chemical synthesis | Indicators and Reagents - chemistry | Bacterial Outer Membrane Proteins - antagonists & inhibitors | Bacterial Outer Membrane Proteins - genetics | Cell Membrane - drug effects | Repressor Proteins - metabolism | Gene Expression | Membrane Proteins - genetics | Oxacillin - pharmacology | Repressor Proteins - genetics | Escherichia coli Proteins - metabolism | Imidazoles - pharmacology | Piperazines - pharmacology | Anti-Bacterial Agents - chemical synthesis | Drug Synergism | Bacterial Outer Membrane Proteins - metabolism | Membrane Proteins - antagonists & inhibitors | Escherichia coli - genetics | Escherichia coli Proteins - genetics | Piperazines - chemical synthesis | Anti-Bacterial Agents - pharmacology | Kinetics | Rifampin - pharmacology | Clarithromycin - pharmacology
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 2016, Volume 60, Issue 8, pp. 5036 - 5039
MICs of 25 and 109 isolates were determined by broth microdilution. Using CLSI breakpoints, the susceptibilities of and isolates were, respectively, 24% and... 
DIAGNOSIS